Literature DB >> 1839162

EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture.

D Casper1, C Mytilineou, M Blum.   

Abstract

Epidermal growth factor (EGF) immunoreactive material has been demonstrated to be present in the basal ganglia. In this study, we investigated the effect of EGF on cells cultured from 16-day embryonic rat mesencephalon, which included dopamine neurons that project to the striatum in vivo. EGF receptors were detected in untreated cultures by [125I]-EGF binding. Treatment of the cultures with EGF resulted in up to 50-fold increases in neuronal high-affinity dopamine uptake. Scatchard analysis of uptake kinetics and counting of tyrosine hydroxylase-immunoreactive cells suggest that the effect of EGF on uptake is due to increased survival and maturation of dopaminergic neurons. By contrast, the high-affinity uptake for serotonin was increased only threefold over its controls. There was no significant effect on high-affinity gamma-aminobutyric acid (GABA) uptake. These results suggest that EGF is acting as a neurotrophic agent preferential for dopaminergic neurons in E16 mesencephalic cultures. Immunocytochemistry for glial fibrillary acidic protein demonstrated an increase in astroglia with EGF treatment. Fluorodeoxyuridine, an agent that is toxic to proliferating cells was able to eliminate the effect of EGF on dopamine uptake, suggesting that EGF may be increasing dopaminergic cell survival largely through a population of dividing cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839162     DOI: 10.1002/jnr.490300213

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  26 in total

Review 1.  Roles of transforming growth factor-alpha and related molecules in the nervous system.

Authors:  C J Xian; X F Zhou
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

2.  Brain-specific tropomyosins TMBr-1 and TMBr-3 have distinct patterns of expression during development and in adult brain.

Authors:  S Stamm; D Casper; J P Lees-Miller; D M Helfman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

3.  Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.

Authors:  J Strelau; A Sullivan; M Böttner; P Lingor; E Falkenstein; C Suter-Crazzolara; D Galter; J Jaszai; K Krieglstein; K Unsicker
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

4.  Increased serum levels of epidermal growth factor in children with autism.

Authors:  Elvan Işeri; Esra Güney; Mehmet F Ceylan; Ayşegül Yücel; Arzu Aral; Sahin Bodur; Sahnur Sener
Journal:  J Autism Dev Disord       Date:  2011-02

Review 5.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

Review 6.  Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.

Authors:  E C Hirsch
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

7.  Sonic Hedgehog Protein : A Novel Approach to the Treatment of Neurodegenerative Disorders?

Authors:  K Pang; T D Ingolia
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

8.  Transplantation of expanded neural precursor cells from the developing pig ventral mesencephalon in a rat model of Parkinson's disease.

Authors:  Richard J E Armstrong; Pamela Tyers; Meena Jain; Andrew Richards; Stephen B Dunnett; Anne E Rosser; Roger A Barker
Journal:  Exp Brain Res       Date:  2003-06-03       Impact factor: 1.972

9.  Clathrin light chain B: gene structure and neuron-specific splicing.

Authors:  S Stamm; D Casper; J Dinsmore; C A Kaufmann; J Brosius; D M Helfman
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

10.  Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action.

Authors:  L A Opanashuk; R J Mark; J Porter; D Damm; M P Mattson; K B Seroogy
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.